HIGH RISK PROSTATE CANCER
Clinical trials for HIGH RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HIGH RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors test radiation 'Paint' to shrink tumors before prostate removal
Disease control Recruiting nowThis trial is testing a new targeted radiation treatment (called Tb-PSMA) given to men with high-risk prostate cancer before they have surgery to remove the prostate. The goal is to see if this pre-surgery treatment is safe and if it helps surgeons remove more of the cancer, redu…
Matched conditions: HIGH RISK PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Rabin Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New Two-Pronged attack on tough prostate cancers before surgery
Disease control Recruiting nowThis study is testing whether a new drug, capivasertib, combined with standard hormone-blocking drugs, can shrink aggressive prostate tumors before surgery. It is for men with high-risk prostate cancer that has a specific genetic feature (PTEN loss) linked to treatment resistance…
Matched conditions: HIGH RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New Triple-Threat attack on aggressive prostate cancer before surgery
Disease control Recruiting nowThis study is testing a combination of three drugs given before surgery (prostate removal) for men with high-risk prostate cancer. The goal is to see if this treatment can shrink the tumor so much that very little cancer is left after surgery. The study will enroll 40 men whose c…
Matched conditions: HIGH RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists test two powerful radiation beams to shrink prostate tumors before removal
Disease control Recruiting nowThis early-stage study is comparing two different targeted radiation drugs for men with high-risk prostate cancer who are planning to have surgery. The goal is to see which drug might be more effective at delivering radiation to the tumor and potentially priming the immune system…
Matched conditions: HIGH RISK PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Hope • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New scan cuts radiation risk for prostate cancer patients
Diagnosis Recruiting nowThis study is testing a modified imaging method for prostate cancer that could reduce radiation exposure. Researchers are comparing a standard two-scan approach against a new method that uses only one CT scan instead of two, while still capturing detailed images. The goal is to m…
Matched conditions: HIGH RISK PROSTATE CANCER
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Feb 24, 2026 14:08 UTC
-
Study probes how men with BRCA genes react to extra risk data
Knowledge-focused Recruiting nowThis study aims to understand how men with BRCA1/2 gene mutations respond to additional genetic risk information. Researchers want to learn how this extra information affects decisions about prostate cancer screening options. The study involves surveys to measure changes in scree…
Matched conditions: HIGH RISK PROSTATE CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC
-
Early test: can new drugs prime immune system to attack prostate cancer before surgery?
Knowledge-focused Recruiting nowThis early study is testing whether giving epigenetic drugs for a few weeks before prostate removal surgery is safe and can make the tumor more visible to the patient's own immune system. It will involve about 20 men with high-risk prostate cancer who are already scheduled for su…
Matched conditions: HIGH RISK PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: Edwin Posadas, MD • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC